相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。STAT3 induces breast cancer growth via ANGPTL4, MMP13 and STC1 secretion by cancer associated fibroblasts
Lidia Avalle et al.
ONCOGENE (2022)
siRNA Drugs: Here to Stay
John J. Rossi et al.
MOLECULAR THERAPY (2021)
Delivery of oligonucleotide-based therapeutics: challenges and opportunities
Suzan M. Hammond et al.
EMBO MOLECULAR MEDICINE (2021)
STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications
Isidora Tosic et al.
NEOPLASIA (2021)
Advances in oligonucleotide drug delivery
Thomas C. Roberts et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
A Deoxyribonucleic Acid Decoy Trapping DUX4 for the Treatment of Facioscapulohumeral Muscular Dystrophy
Virginie Mariot et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression
Juan J. Arroyo-Crespo et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Jiang-Jiang Qin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
STAT3 Targets ERR-α to Promote Epithelial-Mesenchymal Transition, Migration, and Invasion in Triple-Negative Breast Cancer Cells
Jia-Hui Ma et al.
MOLECULAR CANCER RESEARCH (2019)
Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes
Jianye Liu et al.
SCIENCE ADVANCES (2019)
STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
Ioannis Zerdes et al.
CANCERS (2019)
Therapeutic Oligonucleotides: State of the Art
C. I. Edvard Smith et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
Targeting STAT3 in Cancer with Nucleotide Therapeutics
Yue-Ting K. Lau et al.
CANCERS (2019)
STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity
Yu-Lin Su et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non-Small Cell Lung Cancer
Christian Njatcha et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Targeting Transcription Factors for Cancer Treatment
Melanie Lambert et al.
MOLECULES (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer
Sherona R. Sirkisoon et al.
ONCOGENE (2018)
Prevention of Asthma Exacerbation in a Mouse Model by Simultaneous Inhibition of NF-κB and STAT6 Activation Using a Chimeric Decoy Strategy
Tetsuo Miyake et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
The STAT3 Target Gene TNFRSF1A Modulates the NF-κB Pathway in Breast Cancer Cells
Susana P. Egusquiaguirre et al.
NEOPLASIA (2018)
Production of DNA minicircles less than 250 base pairs through a novel concentrated DNA circularization assay enabling minicircle design with NF-κB inhibition activity
Thomas Thibault et al.
NUCLEIC ACIDS RESEARCH (2017)
Pharmacology, pharmacokinetics, and metabolism of the DNA-decoy AYX1 for the prevention of acute and chronic post-surgical pain
Julien Mamet et al.
MOLECULAR PAIN (2017)
Transcription factor decoy technology: A therapeutic update
Markus Hecker et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities
Marcin Kortylewski et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia
Qifang Zhang et al.
BLOOD (2016)
RNAi-mediated gene silencing of vascular endothelial growth factor C suppresses growth and induces apoptosis in mouse breast cancer in vitro and in vivo
Yong-Chao Liu et al.
ONCOLOGY LETTERS (2016)
Local administration of siRNA through Microneedle: Optimization, Bio-distribution, Tumor Suppression and Toxicity
Tao Tang et al.
SCIENTIFIC REPORTS (2016)
Regulation of transcription factors via natural decoys in genomic DNA
Catherine A. Kemme et al.
TRANSCRIPTION-AUSTIN (2016)
Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment
M. Zhang et al.
CANCER GENE THERAPY (2015)
Lipopolyplexes comprising imidazolefimidazolium lipophosphoramidate, histidinylated polyethyleneimine and siRNA as efficient formulation for siRNA transfection
Cristine Goncalves et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Systemic Administration of a Cyclic Signal Transducer and Activator of Transcription 3 (STAT3) Decoy Oligonucleotide Inhibits Tumor Growth without Inducing Toxicological Effects
Malabika Sen et al.
MOLECULAR MEDICINE (2014)
Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
Fritz Eckstein
NUCLEIC ACID THERAPEUTICS (2014)
STAT3 Target Genes Relevant to Human Cancers
Richard L. Carpenter et al.
CANCERS (2014)
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu et al.
NATURE REVIEWS CANCER (2014)
Transcriptional Regulation and Its Misregulation in Disease
Tong Ihn Lee et al.
CELL (2013)
A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model
Keunhee Oh et al.
BREAST CANCER RESEARCH (2013)
First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
Malabika Sen et al.
CANCER DISCOVERY (2012)
A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB
Ines Souissi et al.
BMC CELL BIOLOGY (2011)
Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells
N. Zhao et al.
GENE THERAPY (2011)
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors
Lauren L. C. Marotta et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Systemic Administration of Ribbon-type Decoy Oligodeoxynucleotide Against Nuclear Factor kappa B and Ets Prevents Abdominal Aortic Aneurysm in Rat Model
Takashi Miyake et al.
MOLECULAR THERAPY (2011)
Monitoring intracellular degradation of exogenous DNA using diffusion properties
Akira Sasaki et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Small-Molecule Drugs Mimicking DNA Damage: A New Strategy for Sensitizing Tumors to Radiotherapy
Maria Quanz et al.
CLINICAL CANCER RESEARCH (2009)
Increase in nuclease resistance and incorporation of NF-κB decoy oligodeoxynucteotides by modification of the 3′-terminus
Mariana Kiomy Osako et al.
JOURNAL OF GENE MEDICINE (2007)
Edifoligide: A transcription factor decoy to modulate smooth muscle cell proliferation in vein bypass
Andrew W. Hoel et al.
CARDIOVASCULAR DRUG REVIEWS (2007)
Transcription factor decoy oligonucleotides modified with locked nucleic acids:: an in vitro study to reconcile biostability with binding affinity
R Crinelli et al.
NUCLEIC ACIDS RESEARCH (2004)
分享论文
